Patients from 22+ countriesPlan your visit →
lutetium-therapy
Treatment Abroad · 7 Aug 2026

Planning Your India Trip for Lu-177 PSMA Therapy

If your PSMA-PET scan confirms eligibility and India is on your radar, this guide covers the practical side: visas, flights, accommodation, and what to budget beyond the treatment cost itself.

Editorial oversight by Arpan Talwar·Founder, Art of Healing CancerUpdated 7 Aug 2026
Planning Your India Trip for Lu-177 PSMA Therapy

Before You Book: Seven Steps Every Patient Should Take First

This article is for patients with metastatic castration-resistant prostate cancer (mCRPC) considering lutetium Lu-177 vipivotide tetraxetan therapy - a radioligand treatment that targets PSMA (prostate-specific membrane antigen) on prostate cancer cells. If your PSMA-PET scan has confirmed eligibility and India is on your radar as a treatment destination, this guide covers the practical side: visas, flights, accommodation, and what to budget beyond the treatment cost.

Follow these steps before you book your flights:

  1. Confirm your PSMA-PET eligibility before any booking.
  2. Get an invitation letter from a recognized Indian hospital.
  3. Apply for an India e-Medical Visa - allow two to three weeks.
  4. Plan your first trip around your first one or two cycles.
  5. Decide whether to stay in India between cycles or return home.
  6. Book accommodation within 20 minutes of your treatment center.
  7. Set aside cash for transport, food, and schedule changes beyond the treatment bill.

Confirm Eligibility Before You Commit to Travel

The most common mistake international patients make is booking flights before confirming they qualify for treatment. You can only get Lu-177 PSMA therapy if a PSMA-PET/CT scan shows clear PSMA expression on tumor cells. Without that result, no center can guarantee you will receive treatment when you arrive.

The VISION trial, published in the New England Journal of Medicine in 2021, found that patients with PSMA-positive mCRPC treated with lutetium Lu-177 vipivotide tetraxetan plus standard care had a median overall survival of 15.3 months, compared with 11.3 months for standard care alone. This is why many patients from countries that don't offer it or have high prices want this treatment.

If you want someone to review your existing scans before committing to travel, you can have a nuclear medicine team review your PSMA-PET images and reports remotely through Art of Healing Cancer to confirm whether a trip to India makes sense for your case. Our guide to preparing for a PSMA-PET scan for Lu-177 eligibility explains what the imaging process involves and what the results mean.

The India e-Medical Visa

India issues an e-Medical Visa to international patients seeking treatment at a recognized and accredited hospital. Nationals of 165 countries can apply through India's official e-Visa portal. The visa is valid for 60 days from arrival and you can get it up to twice per calendar year - useful if you plan separate trips for more cycles.

You can bring up to two companions, who can apply for e-Medical Attendant Visas. This matters for patients traveling with a caregiver or family member.

You will generally need:

  • A passport valid for at least six months beyond your planned travel dates.
  • An invitation or treatment letter from a recognized Indian hospital, on official letterhead, confirming your treatment plan.
  • A diagnosis letter or referral from your home-country oncologist.
  • Passport-size photographs and evidence of travel or health insurance.

You submit it online. Fees vary by nationality - check the current schedule at indianvisaonline.gov.in. Processing typically takes three to five business days for a complete application. Do not buy non-refundable flights until your visa is approved.

How Long Do You Need to Stay in India?

A full course of Lu-177 PSMA therapy typically involves up to six cycles, spaced roughly six weeks apart. If all cycles proceed on schedule, the total treatment window spans approximately six to eight months from first to last dose.

Whether to stay in India throughout or fly home between cycles depends largely on where you are traveling from:

  • GCC (UAE, Saudi Arabia, Oman, Qatar, Kuwait): Flights are roughly three to five hours. Most patients return home between cycles, complete local blood work, and fly back for the next dose.
  • East Africa (Kenya, Tanzania, Ethiopia): Flights are five to seven hours. Many patients schedule two cycles per trip, staying four to six weeks at a time.
  • West Africa (Nigeria, Ghana), UK, or Australia: Longer travel times make covering two or three cycles per visit more cost-effective than multiple round trips.

For your first visit, arrive at least two days before your first treatment. Your hospital will need pre-treatment blood tests and a consultation before the first cycle. Our article on traveling safely between Lu-177 PSMA cycles as an international patient covers the radiation safety window that affects when you can fly after each dose - read it before locking in return travel dates.

Flights and Getting to Your Treatment Center

India's main airports for international medical travelers are Indira Gandhi International (Delhi), Chhatrapati Shivaji Maharaj International (Mumbai), Kempegowda International (Bengaluru), and Chennai International. All four cities have nuclear medicine centers offering Lu-177 PSMA therapy. Choose your destination city based on your treatment center, not the cheapest flight - connecting domestically to another city adds fatigue you don't need around a treatment day.

Book flights close to your confirmed treatment dates rather than months in advance. Your hospital schedule may shift slightly based on pre-treatment test results, and flexible return dates reduce the cost of any delays. Ask your treatment team whether you need documentation for airport radiation detectors when flying within two weeks of a cycle.

Long flights can make the first few treatment days harder than expected. If jet lag is a concern, you may want to explore sleep support options before you travel.

Where to Stay During Treatment

Being close to your hospital matters more than paying a low price. Aim for accommodation within 10 to 20 minutes of your treatment center. Most major oncology hospitals in India have international patient departments that offer on-campus lodging or maintain relationships with nearby hotels at reduced rates for medical travelers. Ask for a recommendation from your hospital coordinator when your treatment is confirmed.

Common options for international patients include:

  • Hospital guest houses: Most convenient and sometimes subsidized for longer stays. Limited availability, so book early.
  • Service apartments: Well suited for stays of one month or more; a small kitchen lowers daily food costs compared to eating out for every meal.
  • Nearby hotels: Predictable and convenient, but more expensive per night for extended stays. Ask whether a medical patient rate is available.

A 2022 study of international cancer patients treated at private hospitals in Delhi, published in the Journal of Health Tourism Research, found that monthly accommodation costs for a patient and one companion averaged approximately USD 1,600. This figure varies by city and type of lodging. Always request a current written quote from your hospital before finalizing your travel budget.

What Does the Full Trip Cost? A Budget Planning Guide

Treatment is only part of your total expenditure. The table below summarizes the main cost categories for international patients traveling to India for Lu-177 PSMA therapy.

Estimated costs for international patients traveling to India for Lu-177 PSMA therapy (2024-2025 reference figures)
Budget ItemTypical RangeNotes
Lu-177 PSMA therapy, per cycleINR 1,25,000-2,50,000 (2024)Lower figure reflects domestically produced radioligand; higher figure reflects imported agent. Excludes specialist consultation fees and additional imaging.
Accommodation per month, patient and 1 companionApprox. USD 1,600/month (2022 Delhi reference)Varies by city and accommodation type. Always request a current written quote from your hospital coordinator.
Local transport (airport transfers and hospital visits)Varies - request a quote from hospitalMost hospitals can arrange. Ride-hailing apps are widely available and affordable in major cities.
India e-Medical Visa, per personVaries by nationalityCheck current fees at indianvisaonline.gov.in. Companion attendant visas carry a separate charge.
Return flights per tripVaries by origin countryBook close to confirmed treatment dates. Avoid non-refundable fares until your visa is approved.

Treatment cost source: Rakshit et al., 177Lu-PSMA-617 for metastatic prostate cancer in India, PMC 2024. Accommodation reference: Cancer care medical tourism in the national capital region of India, Journal of Health Tourism Research, 2022.

Even factoring in flights and accommodation, the total cost of a full course of Lu-177 PSMA therapy in India is generally far lower than the cost of a single cycle of lutetium Lu-177 vipivotide tetraxetan (Pluvicto) in markets such as the United States. For a detailed comparison, see our article on Lu-177 PSMA therapy cost in India vs the US.

Practical Steps for Managing Multiple Cycles

Bring complete medical records. Your hospital will need your PSMA-PET/CT scan images and report on a USB drive or CD, recent blood test results, a full oncology treatment history, a current medications list with dosages, and any previous biopsy or pathology reports. A brief summary letter from your home oncologist helps the team understand your case quickly.

Coordinate monitoring with your local doctor between cycles. Your treatment team will specify which blood tests to track in the weeks between cycles. If you return home between doses, brief your local oncologist on what to check and what results should prompt a call to your India team.

Carry your radiation safety card at all times after each cycle. Your hospital will give you a card confirming you received treatment with a radioactive therapeutic agent. Keep it in your wallet for at least two weeks after each dose. Some airports and border checkpoints use radiation detectors that may flag you without this card.

When to Talk to Your Doctor

Before booking any travel, discuss the following with your oncologist:

  • Whether your PSMA-PET result confirms eligibility for Lu-177 PSMA therapy.
  • Whether your blood counts, kidney function, and general health are within range for treatment.
  • Any medications that may need to be reviewed or paused before travel.
  • What follow-up testing your local team should carry out between cycles if you return home between doses.

If you want to submit your scans and reports for an eligibility review before committing to the cost of travel, you can do so through the Lutetium Therapy contact form. If Lu-177 PSMA turns out not to be suitable for your case, the team can also advise on what other options may be worth exploring.

This article is for general information and is not a substitute for medical advice. Always consult your oncologist or care team about your specific situation.

Frequently asked questions

Can I apply for an India e-Medical Visa online?

Yes. India's e-Medical Visa is applied for entirely online through the government portal at indianvisaonline.gov.in and is available to nationals of 165 countries. You will need a hospital invitation letter and a diagnosis or referral letter from your home oncologist. Allow two to three weeks for processing and do not purchase non-refundable flights until approval is confirmed.

How many trips to India will I need for a full course of Lu-177 PSMA therapy?

A standard course involves up to six cycles spaced roughly six weeks apart, spanning approximately six to eight months in total. Whether you need one long stay or multiple trips depends on where you live. Patients from the GCC often return home between cycles given the short flight time. Patients from West Africa, the UK, or Australia typically cover two or three cycles per visit to reduce total flight costs.

What documents should I bring to India for Lu-177 PSMA treatment?

Bring your PSMA-PET/CT scan images and report on a USB drive or CD, all recent blood test results, your complete oncology treatment history, a current medications list with dosages, any previous biopsy or pathology reports, and travel and health insurance documents. A brief summary letter from your home oncologist is also helpful for the team to build your case quickly.

How soon after a cycle of Lu-177 PSMA therapy can I fly home?

Your treatment team will advise on the specific waiting period based on the dose administered and your circumstances. Most centers ask patients to wait at least a few days before flying. You will receive a radiation safety card to carry with you at all times, which is important if airport radiation detectors flag you at the checkpoint. Always follow the specific guidance from your treatment center rather than a general estimate.

Is the cost of Lu-177 PSMA therapy in India much lower than in my home country?

For most international patients, yes. Published data from India indicates that the cost of one treatment cycle using a domestically produced radioligand ranges from approximately INR 1,25,000 to INR 2,50,000 in 2024, depending on the center and whether the radioligand is locally produced or imported. Even after adding flights and accommodation, the total out-of-pocket cost for a full course in India is typically far lower than the listed price of a single cycle of Pluvicto in the United States.

Have a specific question about your situation?

A free conversation with a patient navigator can help you understand whether Lutetium therapy fits your case, what questions to ask your oncologist, and which centers might be right for you.

Navigators don't diagnose or prescribe. They help you have better conversations with the doctors who do.